Back to search

Article

Reporting of Health-Related Quality of Life Outcome Measures in Genotype based Targeted Therapies for Advanced Cancers

2025-07-31

Abstract excerpt

<title>Abstract</title> <p>Background Genotype based matched targeted therapies (MTT) trials have shown clinical benefit in patients with advanced cancer however health-related quality of life (HRQoL) outcomes are often inconsistently reported in these trials. In this study, we evaluated the overall reporting and quality of HRQoL based randomised controlled trials (RCTs). Methods We searched various biomedical da...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ad3df2c0-9930-5bd6-bd9c-1df6ac718c41
DOI
10.21203/rs.3.rs-7091849/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Reporting of Health-Related Quality of Life Outcome Measures in Genotype based Targeted Therapies for Advanced CancersDOI 10.21203/rs.3.rs-7091849/v1
An Evidenced-Based Prior for Estimating the Treatment Effect of Phase III Randomized Trials in OncologySemantic proximity
Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.Semantic proximity
The Current Landscape of Clinical TrialsSemantic proximity
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trialSemantic proximity
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trialSemantic proximity
Randomized clinical trials with biomarkers: design issues.Semantic proximity
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.Semantic proximity
Comparison of the sensitivities of pharmacotherapy-related and disease-specific quality of life measures in response to pharmacist-led pharmaceutical care for cancer outpatients: a randomised controlled trialSemantic proximity
Examining the Feasibility and Functionality of Common Analysis Methods for Longitudinal Data with Binary OutcomesSemantic proximity
QUEST: Quality of Life and Evaluation of Survival in Treatment of Bladder Cancer – A Prospective Study on Quality of Life and Survival of Bladder Cancer Patients Using Patient-Reported Outcome Measurements (PROMs)Semantic proximity
Cancer clinical trials : identifying & testing approaches to impact evaluationSemantic proximity
Health-related quality of life and associated factors among patients with liver cancerSemantic proximity
Select a neighboring publication to make it the new centre.